Grifols signs 7-yr contract with Japan's Red Cross for $375 mln

MADRID, March 31 Mon Mar 31, 2014 2:56am EDT

Related Topics

MADRID, March 31 (Reuters) - Spanish blood products company Grifols has signed a 7-year, $375-million contract to conduct blood analysis for Japan's Red Cross, the company said in a statement to the stock market regulator on Monday.

The contract to analyze 5.3 million blood transfusions a year for HIV and hepatitis and other infections was signed by Grifols unit Novartis Pharma, the Spanish group said.

Grifols acquired the blood transfusion testing unit of Novartis in January. (Reporting by Paul Day; Editing by Fiona Ortiz)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.